Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Core Molecular Diagnostic Lab, |
RCV000755051 | SCV000882825 | pathogenic | Ethylmalonic encephalopathy | 2019-02-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001557377 | SCV001779130 | likely pathogenic | not provided | 2017-06-13 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016; McVean et al., 2012; Exome Variant Server); In silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect; This variant is associated with the following publications: (PMID: 30349987, 19289697) |
Baylor Genetics | RCV000755051 | SCV004192688 | likely pathogenic | Ethylmalonic encephalopathy | 2024-03-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001557377 | SCV005329778 | likely pathogenic | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | ETHE1: PM3:Strong, PM2, PP3, PP4 |
Natera, |
RCV000755051 | SCV002088909 | likely pathogenic | Ethylmalonic encephalopathy | 2020-09-03 | no assertion criteria provided | clinical testing | |
OMIM | RCV000755051 | SCV005375484 | pathogenic | Ethylmalonic encephalopathy | 2024-10-22 | no assertion criteria provided | literature only |